| 1 | ANKRD9, IMPDH2
|
| ANKRD9 is a metabolically-controlled regulator of IMPDH2 abundance and macro-assembly.
|
| Hayward D, Kouznetsova VL, Pierson HE, Hasan NM, Guzman ER, Tsigelny IF, Lutsenko S.
|
| Biol Chem. Sep 27;294(39):14454-14466. doi: 10.1074/jbc.RA119.008231. Epub 2019 Jul 23 2019
|
| 2 | CTPS1, iMPDH2
|
| Glutamine deprivation initiates reversible assembly of mammalian rods and rings.
|
| Calise SJ, Carcamo WC, Krueger C, Yin JD, Purich DL, Chan EK.
|
| Cell Mol Life Sci 71(15):2963-73. doi: 10.1007/s00018-014-1567-6. Epub 2014 Jan 30.
2014
|
| 3 | IMPDH2, TLR2
|
| IMPDHII protein inhibits Toll-like receptor 2-mediated activation of NF-kappaB.
|
| Toubiana J, Rossi AL, Grimaldi D, Belaidouni N, Chafey P, Clary G, Courtine E, Pene F, Mira JP, Claessens YE, Chiche JD.
|
| J Biol Chem 286(26):23319-33. Epub 2011 Apr 1.
2011
|
| 4 | IMPDH1, IMPDH2
|
| Pharmacogenetics of the mycophenolic acid targets inosine monophosphate dehydrogenases IMPDH1 and IMPDH2: gene sequence variation and functional genomics.
|
| Wu TY, Peng Y, Pelleymounter LL, Moon I, Eckloff BW, Wieben ED, Yee VC, Weinshilboum RM.
|
| Br J Pharmacol 161(7):1584-98. doi: 10.1111/j.1476-5381.2010.00987.x. 2010
|
| 5 | IMPDH2
|
| Overexpression of inosine 5'-monophosphate dehydrogenase type II mediates chemoresistance to human osteosarcoma cells.
|
| Fellenberg J, Kunz P, Sähr H, Depeweg D.
|
| PLoS One 5(8):e12179. 2010
|
| 6 | IMPDH2
|
| An inosine 5'-monophosphate dehydrogenase 2 single-nucleotide polymorphism impairs the effect of mycophenolic acid.
|
| Winnicki W, Weigel G, Sunder-Plassmann G, Bajari T, Winter B, Herkner H, Sengoelge G.
|
| Pharmacogenomics J 10(1):70-6. Epub 2009 Sep 22. 2010
|
| 7 | IMPDH1, IMPDH2
|
| IMPDH2 genetic polymorphism: a promoter single-nucleotide polymorphism disrupts a cyclic adenosine monophosphate responsive element.
|
| Garat A, Cauffiez C, Hamdan-Khalil R, Glowacki F, Devos A, Leclerc J, Lionet A, Allorge D, Lo-Guidice JM, Broly F.
|
| Genet Test Mol Biomarkers 13(6):841-7. 2009
|
| 8 | IMPDH2
|
| Identification of IMPDH2 as a tumor-associated antigen in colorectal cancer using immunoproteomics analysis.
|
| He Y, Mou Z, Li W, Liu B, Fu T, Zhao S, Xiang D, Wu Y.
|
| Int J Colorectal Dis 24(11):1271-9. Epub 2009 Jul 14. 2009
|
| 9 | IMPDH2
|
| Prognostic significance of drug-regulated genes in high-grade osteosarcoma.
|
| Fellenberg J, Bernd L, Delling G, Witte D, Zahlten-Hinguranage A.
|
| Mod Pathol 20(10):1085-94. Epub 2007 Jul 27. 2007
|
| 10 | IMPDH2
|
| Assignment of inosine 5'-monophosphate dehydrogenase type 2 (IMPDH2) to human chromosome band 3p21.2 by in situ hybridization.
|
| Kost-Alimova MV, et al.
|
| Cytogenet Cell Genet 82 : 145-146. 1998
|
| 11 | IMPDH1, IMPDH2
|
| Recombinant human inosine monophosphate dehydrogenase type I and type II proteins. Purification and characterization of inhibitor binding.
|
| Hager PW, Collart FR, Huberman E, Mitchell BS.
|
| Biochem Pharmacol 49(9):1323-9.
1995
|
| 12 | IMPDH2
|
| Chromosomal localization and structure of the human type II IMP dehydrogenase gene (IMPDH2).
|
| Glesne D, et al.
|
| Genomics 16 : 274-277. 1993
|